CellaVision AB (CEVI) - Total Liabilities

Latest as of December 2025: Skr207.31 Million SEK ≈ $22.31 Million USD

Based on the latest financial reports, CellaVision AB (CEVI) has total liabilities worth Skr207.31 Million SEK (≈ $22.31 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore CEVI net asset momentum to track the company's year-over-year net asset growth rate.

CellaVision AB - Total Liabilities Trend (2000–2025)

This chart illustrates how CellaVision AB's total liabilities have evolved over time, based on quarterly financial data. See CEVI FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

CellaVision AB Competitors by Total Liabilities

The table below lists competitors of CellaVision AB ranked by their total liabilities.

Company Country Total Liabilities
Taiwan Steel Union Co Ltd
TW:6581
Taiwan NT$818.73 Million
Xinjiang Chalkis Co Ltd
SHE:000972
China CN¥1.42 Billion
Beijing Haohan Data Technology Co. Ltd. A
SHG:688292
China CN¥474.86 Million
Guangdong PAK Corporation Co Ltd
SHE:300625
China CN¥896.13 Million
Grupo Traxión S.A.B. de C.V
MX:TRAXIONA
Mexico MX$21.16 Billion
Zhejiang Talent Television&Film Co Ltd
SHE:300426
China CN¥1.63 Billion
Sinopec Oilfield Service Corporation
F:YIZH
Germany €66.96 Billion
Kenmec Mechanical Engineering Co Ltd
TWO:6125
Taiwan NT$5.97 Billion

Liability Composition Analysis (2000–2025)

This chart breaks down CellaVision AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is CellaVision AB worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.98 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.23 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.19 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how CellaVision AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for CellaVision AB (2000–2025)

The table below shows the annual total liabilities of CellaVision AB from 2000 to 2025.

Year Total Liabilities Change
2025-12-31 Skr207.31 Million
≈ $22.31 Million
+5.68%
2024-12-31 Skr196.16 Million
≈ $21.11 Million
-7.61%
2023-12-31 Skr212.32 Million
≈ $22.85 Million
-15.11%
2022-12-31 Skr250.12 Million
≈ $26.92 Million
-11.28%
2021-12-31 Skr281.93 Million
≈ $30.34 Million
+18.26%
2020-12-31 Skr238.41 Million
≈ $25.66 Million
-18.73%
2019-12-31 Skr293.34 Million
≈ $31.57 Million
+255.96%
2018-12-31 Skr82.41 Million
≈ $8.87 Million
+37.93%
2017-12-31 Skr59.75 Million
≈ $6.43 Million
+18.85%
2016-12-31 Skr50.27 Million
≈ $5.41 Million
+36.20%
2015-12-31 Skr36.91 Million
≈ $3.97 Million
-27.56%
2014-12-31 Skr50.95 Million
≈ $5.48 Million
-9.11%
2013-12-31 Skr56.06 Million
≈ $6.03 Million
+4.50%
2012-12-31 Skr53.64 Million
≈ $5.77 Million
+1.87%
2011-12-31 Skr52.66 Million
≈ $5.67 Million
+7.30%
2010-12-31 Skr49.08 Million
≈ $5.28 Million
+27.30%
2009-12-31 Skr38.55 Million
≈ $4.15 Million
-23.64%
2008-12-31 Skr50.49 Million
≈ $5.43 Million
+109.95%
2007-12-31 Skr24.05 Million
≈ $2.59 Million
+1.92%
2006-12-31 Skr23.60 Million
≈ $2.54 Million
+19.90%
2005-12-31 Skr19.68 Million
≈ $2.12 Million
-27.03%
2004-12-31 Skr26.97 Million
≈ $2.90 Million
+20.07%
2003-12-31 Skr22.46 Million
≈ $2.42 Million
-10.24%
2002-12-31 Skr25.02 Million
≈ $2.69 Million
-23.58%
2001-12-31 Skr32.74 Million
≈ $3.52 Million
+79.77%
2000-12-31 Skr18.21 Million
≈ $1.96 Million
--

About CellaVision AB

ST:CEVI Sweden Medical Devices
Market Cap
$379.89 Million
Skr3.53 Billion SEK
Market Cap Rank
#13583 Global
#218 in Sweden
Share Price
Skr148.00
Change (1 day)
+0.54%
52-Week Range
Skr118.40 - Skr188.40
All Time High
Skr478.48
About

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides digital hematology microscopy solutions, covering analyzers and instruments; and hardware products, including in vitro diagnostics IVD for laboratories; smear makers, stainers, stains, and staining protocols; DIFF-Line, a hematology la… Read more